Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Every Six-Month versus Single-Dose Adjuvant Zoledronate in Early Breast Cancer.
Journal: NEJM evidence
Published: May 26, 2026
MammaPrint predicts chemotherapy benefit in HR+HER2- early breast cancer: FLEX Registry real-world data.
Journal: JNCI cancer spectrum
Published: April 22, 2025
A Scoping Review of the Current Knowledge of the Social Determinants of Health and Infectious Diseases (Specifically COVID-19, Tuberculosis, and H1N1 Influenza) in Canadian Arctic Indigenous Communities.
Journal: International journal of environmental research and public health
Published: September 20, 2024
A randomised trial comparing 6-monthly adjuvant zoledronate with a single one-time dose in patients with early breast cancer.
Journal: Breast cancer research and treatment
Published: April 22, 2024
Pembrolizumab plus Abiraterone Acetate and Prednisone in Patients with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Results from KEYNOTE-365 Cohort D.
Journal: European urology oncology
Published: December 06, 2023
Comparison of tumor-agnostic and tumor-specific clinical oncology trial designs: a systematic review and meta-analysis.
Journal: Future oncology (London, England)
Published: June 07, 2023
Pembrolizumab and Enzalutamide in Patients with Abiraterone Acetate-Pretreated Metastatic Castration-Resistant Prostate Cancer: Cohort C of the Phase 1b/2 KEYNOTE-365 Study.
Journal: European urology oncology
Published: March 15, 2023
A Guide to Implementing Immune Checkpoint Inhibitors within a Cancer Program: Experience from a Large Canadian Community Centre.
Journal: Current oncology (Toronto, Ont.)
Published: December 23, 2021
Pembrolizumab Plus Docetaxel and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort B Study.
Journal: European urology
Published: October 14, 2021
Feasibility outcomes of a randomised, multicentre, pilot trial comparing standard 6-monthly dosing of adjuvant zoledronate with a single one-time dose in patients with early stage breast cancer.
Journal: Journal of bone oncology
Published: November 10, 2020
Quality of written feedback given to medical students after introduction of real-time audio monitoring of clinical encounters.
Journal: BMC medical education
Published: April 03, 2020
Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III Trial.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: March 12, 2020
Last Updated: 09/26/2026